Stockscreener 앱 받기
339.16
0.17%
-0.45
전일 마감가:
$339.61
열려 있는:
$339.16
하루 거래량:
62,193
Relative Volume:
0.07
시가총액:
$13.30B
수익:
$1.24B
순이익/손실:
$42.23M
주가수익비율:
319.96
EPS:
1.06
순현금흐름:
$150.33M
1주 성능:
-0.85%
1개월 성능:
-0.87%
6개월 성능:
+20.45%
1년 성능:
+18.38%
1일 변동 폭
$338.50
$339.95
1주일 범위
$338.50
$344.53
52주 변동 폭
$221.26
$362.41
Penumbra Inc Stock (PEN) Company Profile
명칭
Penumbra Inc
전화
(510) 995-2486
주소
ONE PENUMBRA PLACE, ALAMEDA, CA
Compare PEN vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PEN
Penumbra Inc
|
339.00 | 13.32B | 1.24B | 42.23M | 150.33M | 1.06 |
|
ABT
Abbott Laboratories
|
111.62 | 196.53B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
375.79 | 146.14B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
93.55 | 122.74B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
71.54 | 107.15B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
84.63 | 49.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Penumbra Inc Stock (PEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-18 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-11-18 | 개시 | Wells Fargo | Underweight |
| 2025-10-08 | 업그레이드 | Needham | Hold → Buy |
| 2025-09-02 | 개시 | Evercore ISI | Outperform |
| 2025-03-14 | 개시 | BofA Securities | Buy |
| 2025-01-21 | 개시 | UBS | Buy |
| 2024-12-17 | 개시 | Oppenheimer | Outperform |
| 2024-12-11 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-09-18 | 개시 | Stifel | Buy |
| 2024-09-03 | 개시 | Leerink Partners | Outperform |
| 2024-07-31 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-07-31 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-02-23 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2023-09-06 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-03-29 | 다운그레이드 | Needham | Buy → Hold |
| 2023-01-30 | 개시 | Piper Sandler | Overweight |
| 2022-11-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-10-05 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-09-09 | 업그레이드 | Needham | Hold → Buy |
| 2022-07-18 | 개시 | RBC Capital Mkts | Outperform |
| 2022-04-19 | 개시 | Deutsche Bank | Buy |
| 2022-03-08 | 개시 | Needham | Hold |
| 2021-09-16 | 개시 | Truist | Buy |
| 2021-06-04 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-12-16 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-10-07 | 재개 | Canaccord Genuity | Buy |
| 2020-09-29 | 개시 | BTIG Research | Buy |
| 2020-09-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-06-13 | 재확인 | BofA/Merrill | Buy |
| 2019-05-30 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-05-21 | 개시 | William Blair | Outperform |
| 2018-10-29 | 재개 | BofA/Merrill | Buy |
| 2018-10-08 | 개시 | RBC Capital Mkts | Outperform |
| 2018-02-21 | 개시 | William Blair | Outperform |
| 2018-01-02 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2015-11-30 | 재확인 | Canaccord Genuity | Buy |
| 2015-10-13 | 개시 | Wells Fargo | Outperform |
모두보기
Penumbra Inc 주식(PEN)의 최신 뉴스
Insider Sell: Maggie Yuen Sells Shares of Penumbra Inc (PEN) - GuruFocus
NZS Capital LLC Buys 17,355 Shares of Penumbra, Inc. $PEN - MarketBeat
Boston Scientific (NYSE: BSX) Explains Rationale for Penumbra Deal - Stock Titan
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—THR, PEN, BCO, and ALGT - Carroll County Mirror-Democrat
Champlain Investment Partners LLC Trims Holdings in Penumbra, Inc. $PEN - MarketBeat
Broker files Form 144 reporting PEN share sales (NYSE: PEN) - Stock Titan
(PEN) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
PEN Stock Up Following Q4 Earnings & Revenue Beat, Margins Rise - The Globe and Mail
Penumbra, Inc. (PEN) Stock Analysis: Unveiling the Potential in Medical Devices with a 4.57% Upside - DirectorsTalk Interviews
Citigroup Inc. Grows Stock Holdings in Penumbra, Inc. $PEN - MarketBeat
TD Asset Management Inc Sells 8,742 Shares of Penumbra, Inc. $PEN - MarketBeat
Artisan Partners Limited Partnership Raises Position in Penumbra, Inc. $PEN - MarketBeat
PEN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Penumbra, Inc. $PEN Shares Acquired by Intech Investment Management LLC - MarketBeat
UBS Maintains Neutral on Penumbra (PEN) Feb 26, 2026 - Meyka
Penumbra (PEN) Earnings Surge Challenges Concerns Over Rich 75x P/E Valuation - simplywall.st
UBS reiterates Neutral on Penumbra stock, keeps $374 target By Investing.com - Investing.com Canada
Evercore ISI Maintains Outperform Rating and Raises PT for PEN t - GuruFocus
UBS reiterates Neutral on Penumbra stock, keeps $374 target - Investing.com
Penumbra, Inc. (NYSE:PEN) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Decoding Penumbra Inc (PEN): A Strategic SWOT Insight - GuruFocus
Boston Scientific Still Navigating the Regulatory Process to Acquire Penumbra - Morningstar
Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results | BSX Stock News - Longbridge
Evercore ISI Maintained Outperform for Penumbra, Inc. (PEN) Feb 25, 2026 - Meyka
Evercore ISI raises Penumbra stock price target on embolization growth - Investing.com Nigeria
Compared to Estimates, Penumbra (PEN) Q4 Earnings: A Look at Key Metrics - Yahoo Finance
Penumbra (PEN) Surpasses Q4 Earnings and Revenue Estimates - Yahoo Finance
Penumbra (NYSE:PEN) Reports Bullish Q4 CY2025 - Finviz
Evercore ISI raises Penumbra stock price target on embolization growth By Investing.com - Investing.com South Africa
Penumbra, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financi - GuruFocus
Penumbra: Fourth Quarter Earnings Overview - Bitget
Penumbra (NYSE:PEN) Announces Quarterly Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat
Penumbra Inc SEC 10-K Report - TradingView
Penumbra: Q4 Earnings Snapshot - marketscreener.com
Penumbra Q4 Non-GAAP Earnings, Revenue Rise - marketscreener.com
Penumbra Inc. (PEN) Releases Q4 2025 Earnings: Revenue and EPS Beat, Strong YoY Growth - Quiver Quantitative
Earnings Flash (PEN) Penumbra, Inc. Reports Q4 Revenue $385.4M, vs. FactSet Est of $361.9M - marketscreener.com
Earnings Flash (PEN) Penumbra, Inc. Posts Q4 Adjusted EPS $1.18 per Share, vs. FactSet Est of $1.11 - marketscreener.com
Penumbra Q4 Earnings Assessment - Benzinga
Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results - TradingView
Penumbra (NYSE: PEN) grows 2025 revenue 17.5% amid BSX acquisition - Stock Titan
Penumbra Inc (NYSE:PEN) Combines Strong Fundamentals with Bullish Technical Setup - ChartMill
Penumbra, Inc. (PEN) Stock Analysis: Navigating Healthcare Innovation with a 2.70% Upside - DirectorsTalk Interviews
Penumbra earnings on deck as Boston Scientific deal looms By Investing.com - Investing.com South Africa
PEN (Penumbra) Retained Earnings : $190 Mil (As of Sep. 2025) - GuruFocus
PEN (Penumbra) Sale Of Investment : $18 Mil (TTM As of Sep. 2025) - GuruFocus
Chipmakers Recap: Is Penumbra Inc on track to beat earnings2025 Major Catalysts & Safe Capital Allocation Plans - baoquankhu1.vn
Vanguard Group Inc. Sells 25,172 Shares of Penumbra, Inc. $PEN - MarketBeat
Analysts Offer Insights on Healthcare Companies: Penumbra (PEN), Orchestra BioMed Holdings (OBIO) and Teladoc (TDOC) - The Globe and Mail
Boston Scientific’s $14.5B Penumbra Mega-Merger: A Strategic Reshaping of the Medtech Landscape - FinancialContent
Penumbra Inc (PEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.60%
자본화:
|
볼륨(24시간):